Original data (with adjusted standard errors for multi-arm studies):

              treat1      treat2      TE   seTE seTE.adj.f seTE.adj.r narms multiarm
2            placebo    zolpidem -1.0823 1.6380     1.6380     1.6380     2         
6        eszopiclone     placebo  0.4692 0.4399     0.4399     0.4399     2         
10           placebo    zolpidem -1.1758 0.8237     0.8237     0.8237     2         
25           placebo    zaleplon -0.8690 0.7896     1.0051     1.0051     3        *
25           placebo    zolpidem -1.3281 0.8122     1.1519     1.1519     3        *
25          zaleplon    zolpidem -0.4591 0.5167     0.5490     0.5490     3        *
32           placebo    zaleplon -0.0000 0.6229     0.7799     0.7799     3        *
32          zaleplon    zolpidem -0.6041 0.5304     0.5977     0.5977     3        *
32           placebo    zolpidem -0.6041 0.6408     0.8453     0.8453     3        *
39           placebo    zolpidem -0.9019 0.6036     0.6036     0.6036     2         
43           placebo    zaleplon -0.0426 0.4700     0.4700     0.4700     2         
49          zaleplon    zolpidem  0.7376 1.2605     1.2605     1.2605     2         
61           doxepin     placebo  0.9297 1.1046     1.1046     1.1046     2         
63           doxepin     placebo -0.0476 1.4198     1.4198     1.4198     2         
65         melatonin     placebo -1.0398 1.6402     1.6402     1.6402     2         
66  BZD-intermediate     placebo -0.3621 0.6070     0.7675     0.7675     4        *
66         BZD-short     placebo -0.3747 0.6069     0.7673     0.7673     4        *
66           placebo    zolpidem  1.2910 0.8175     1.1915     1.1915     4        *
66  BZD-intermediate   BZD-short  0.0126 0.6520     0.8963     0.8963     4        *
66  BZD-intermediate    zolpidem  0.9289 0.8516     1.3919     1.3919     4        *
66         BZD-short    zolpidem  0.9163 0.8515     1.3914     1.3914     4        *
67  BZD-intermediate     placebo  0.1589 0.5649     0.5649     0.5649     2         
68  BZD-intermediate   zopiclone  0.7062 1.2354     1.2354     1.2354     2         
77       eszopiclone     placebo -0.4750 0.9213     0.9213     0.9213     2         
83  BZD-intermediate     placebo  2.1041 1.5465     1.5465     1.5465     2         
89           placebo   ramelteon -0.0364 0.5413     0.5413     0.5413     2         
90           placebo   ramelteon  0.0364 1.4168     1.4168     1.4168     2         
91           doxepin   ramelteon -0.0000 0.8272     0.9563     0.9563     3        *
91           placebo   ramelteon -0.4651 0.9222     1.1656     1.1656     3        *
91           doxepin     placebo  0.4651 0.9222     1.1656     1.1656     3        *
92           placebo   ramelteon -1.5826 1.5578     1.5578     1.5578     2         
99      daridorexant    zolpidem -0.7057 1.1655     1.2598     1.2598     3        *
99           placebo    zolpidem -1.1153 1.6432     2.1776     2.1776     3        *
99      daridorexant     placebo  0.4096 1.6406     2.1640     2.1640     3        *
105          placebo    zolpidem -0.9214 0.7053     0.7053     0.7053     2         
106      eszopiclone   zopiclone -0.5635 0.4420     0.4420     0.4420     2         
114          placebo    zolpidem -1.2164 0.8285     0.8285     0.8285     2         
115          placebo   ramelteon  0.1373 0.5247     0.5247     0.5247     2         
120      eszopiclone     placebo -1.1905 0.7439     0.7439     0.7439     2         
122          placebo   zopiclone -0.7621 1.6745     1.6745     1.6745     2         
127          placebo   ramelteon -0.2856 0.5439     0.5439     0.5439     2         
129        melatonin     placebo -1.1100 1.1596     1.1596     1.1596     2         
130        melatonin     placebo  0.4106 0.9157     0.9157     0.9157     2         
132          placebo   trazodone -0.9874 0.8487     1.1094     1.1094     3        *
132        trazodone    zolpidem  0.0208 0.6487     0.7125     0.7125     3        *
132          placebo    zolpidem -0.9666 0.8486     1.1088     1.1088     3        *
134          placebo    zaleplon -1.1537 1.1705     1.1705     1.1705     2         
135          placebo    zolpidem -1.4116 1.1293     1.1293     1.1293     2         
137          placebo    zolpidem -1.1767 1.6390     1.6390     1.6390     2         
142 BZD-intermediate     placebo  2.0541 1.5473     1.5473     1.5473     2         
144      eszopiclone     placebo  1.2158 1.5168     1.5168     1.5168     2         
145          placebo   ramelteon -0.6477 0.8747     0.8747     0.8747     2         
149 BZD-intermediate   trazodone -0.9605 1.5014     1.5014     1.5014     2         
153      lemborexant    zolpidem -0.9061 0.6103     0.6638     0.6638     3        *
153          placebo    zolpidem -0.8774 0.8218     1.0497     1.0497     3        *
153      lemborexant     placebo -0.0287 0.8407     1.1421     1.1421     3        *
158          placebo seltorexant  0.3730 0.8766     1.0114     1.0114     3        *
158          placebo    zolpidem -0.0278 1.0138     1.4369     1.4369     3        *
158      seltorexant    zolpidem -0.4008 0.8768     1.0118     1.0118     3        *

Number of treatment arms (by study):
    narms
2       2
6       2
10      2
25      3
32      3
39      2
43      2
49      2
61      2
63      2
65      2
66      4
67      2
68      2
77      2
83      2
89      2
90      2
91      3
92      2
99      3
105     2
106     2
114     2
115     2
120     2
122     2
127     2
129     2
130     2
132     3
134     2
135     2
137     2
142     2
144     2
145     2
149     2
153     3
158     3

Results (fixed effects model):

              treat1      treat2     OR           95%-CI    Q leverage
2            placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.04     0.02
6        eszopiclone     placebo 0.9824 [0.5183; 1.8620] 1.23     0.55
10           placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.27     0.07
25           placebo    zaleplon 0.7511 [0.4338; 1.3005] 0.34        .
25           placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.25        .
25          zaleplon    zolpidem 0.6303 [0.3594; 1.1056] 0.00        .
32           placebo    zaleplon 0.7511 [0.4338; 1.3005] 0.13        .
32          zaleplon    zolpidem 0.6303 [0.3594; 1.1056] 0.06        .
32           placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.03        .
39           placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.07     0.13
43           placebo    zaleplon 0.7511 [0.4338; 1.3005] 0.27     0.36
49          zaleplon    zolpidem 0.6303 [0.3594; 1.1056] 0.90     0.05
61           doxepin     placebo 1.5105 [0.4929; 4.6292] 0.22     0.27
63           doxepin     placebo 1.5105 [0.4929; 4.6292] 0.10     0.16
65         melatonin     placebo 0.7313 [0.2013; 2.6569] 0.20     0.16
66  BZD-intermediate     placebo 1.5087 [0.7503; 3.0340] 1.02        .
66         BZD-short     placebo 1.2311 [0.4155; 3.6479] 0.58        .
66           placebo    zolpidem 0.4734 [0.3085; 0.7265] 2.93        .
66  BZD-intermediate   BZD-short 1.2255 [0.3902; 3.8495] 0.05        .
66  BZD-intermediate    zolpidem 0.7143 [0.3237; 1.5761] 0.83        .
66         BZD-short    zolpidem 0.5828 [0.1870; 1.8166] 1.10        .
67  BZD-intermediate     placebo 1.5087 [0.7503; 3.0340] 0.20     0.40
68  BZD-intermediate   zopiclone 0.9445 [0.3076; 2.9001] 0.38     0.21
77       eszopiclone     placebo 0.9824 [0.5183; 1.8620] 0.25     0.13
83  BZD-intermediate     placebo 1.5087 [0.7503; 3.0340] 1.20     0.05
89           placebo   ramelteon 0.8204 [0.4867; 1.3828] 0.09     0.24
90           placebo   ramelteon 0.8204 [0.4867; 1.3828] 0.03     0.04
91           doxepin   ramelteon 1.2392 [0.3899; 3.9389] 0.05        .
91           placebo   ramelteon 0.8204 [0.4867; 1.3828] 0.05        .
91           doxepin     placebo 1.5105 [0.4929; 4.6292] 0.00        .
92           placebo   ramelteon 0.8204 [0.4867; 1.3828] 0.79     0.03
99      daridorexant    zolpidem 0.5419 [0.0640; 4.5909] 0.01        .
99           placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.03        .
99      daridorexant     placebo 1.1447 [0.1323; 9.9035] 0.02        .
105          placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.06     0.10
106      eszopiclone   zopiclone 0.6149 [0.2759; 1.3705] 0.03     0.86
114          placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.32     0.07
115          placebo   ramelteon 0.8204 [0.4867; 1.3828] 0.41     0.26
120      eszopiclone     placebo 0.9824 [0.5183; 1.8620] 2.49     0.19
122          placebo   zopiclone 0.6260 [0.2396; 1.6354] 0.03     0.09
127          placebo   ramelteon 0.8204 [0.4867; 1.3828] 0.03     0.24
129        melatonin     placebo 0.7313 [0.2013; 2.6569] 0.47     0.32
130        melatonin     placebo 0.7313 [0.2013; 2.6569] 0.62     0.52
132          placebo   trazodone 0.4039 [0.1307; 1.2477] 0.01        .
132        trazodone    zolpidem 1.1722 [0.3875; 3.5462] 0.04        .
132          placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.04        .
134          placebo    zaleplon 0.7511 [0.4338; 1.3005] 0.55     0.06
135          placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.35     0.04
137          placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.07     0.02
142 BZD-intermediate     placebo 1.5087 [0.7503; 3.0340] 1.13     0.05
144      eszopiclone     placebo 0.9824 [0.5183; 1.8620] 0.66     0.05
145          placebo   ramelteon 0.8204 [0.4867; 1.3828] 0.26     0.09
149 BZD-intermediate   trazodone 0.6094 [0.1721; 2.1575] 0.10     0.18
153      lemborexant    zolpidem 0.4175 [0.1349; 1.2926] 0.00        .
153          placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.02        .
153      lemborexant     placebo 0.8819 [0.2739; 2.8402] 0.01        .
158          placebo seltorexant 1.0132 [0.2453; 4.1844] 0.13        .
158          placebo    zolpidem 0.4734 [0.3085; 0.7265] 0.25        .
158      seltorexant    zolpidem 0.4673 [0.1131; 1.9297] 0.13        .

Results (random effects model):

              treat1      treat2     OR           95%-CI
2            placebo    zolpidem 0.4734 [0.3085; 0.7265]
6        eszopiclone     placebo 0.9824 [0.5183; 1.8620]
10           placebo    zolpidem 0.4734 [0.3085; 0.7265]
25           placebo    zaleplon 0.7511 [0.4338; 1.3005]
25           placebo    zolpidem 0.4734 [0.3085; 0.7265]
25          zaleplon    zolpidem 0.6303 [0.3594; 1.1056]
32           placebo    zaleplon 0.7511 [0.4338; 1.3005]
32          zaleplon    zolpidem 0.6303 [0.3594; 1.1056]
32           placebo    zolpidem 0.4734 [0.3085; 0.7265]
39           placebo    zolpidem 0.4734 [0.3085; 0.7265]
43           placebo    zaleplon 0.7511 [0.4338; 1.3005]
49          zaleplon    zolpidem 0.6303 [0.3594; 1.1056]
61           doxepin     placebo 1.5105 [0.4929; 4.6292]
63           doxepin     placebo 1.5105 [0.4929; 4.6292]
65         melatonin     placebo 0.7313 [0.2013; 2.6569]
66  BZD-intermediate     placebo 1.5087 [0.7503; 3.0340]
66         BZD-short     placebo 1.2311 [0.4155; 3.6479]
66           placebo    zolpidem 0.4734 [0.3085; 0.7265]
66  BZD-intermediate   BZD-short 1.2255 [0.3902; 3.8495]
66  BZD-intermediate    zolpidem 0.7143 [0.3237; 1.5761]
66         BZD-short    zolpidem 0.5828 [0.1870; 1.8166]
67  BZD-intermediate     placebo 1.5087 [0.7503; 3.0340]
68  BZD-intermediate   zopiclone 0.9445 [0.3076; 2.9001]
77       eszopiclone     placebo 0.9824 [0.5183; 1.8620]
83  BZD-intermediate     placebo 1.5087 [0.7503; 3.0340]
89           placebo   ramelteon 0.8204 [0.4867; 1.3828]
90           placebo   ramelteon 0.8204 [0.4867; 1.3828]
91           doxepin   ramelteon 1.2392 [0.3899; 3.9389]
91           placebo   ramelteon 0.8204 [0.4867; 1.3828]
91           doxepin     placebo 1.5105 [0.4929; 4.6292]
92           placebo   ramelteon 0.8204 [0.4867; 1.3828]
99      daridorexant    zolpidem 0.5419 [0.0640; 4.5909]
99           placebo    zolpidem 0.4734 [0.3085; 0.7265]
99      daridorexant     placebo 1.1447 [0.1323; 9.9035]
105          placebo    zolpidem 0.4734 [0.3085; 0.7265]
106      eszopiclone   zopiclone 0.6149 [0.2759; 1.3705]
114          placebo    zolpidem 0.4734 [0.3085; 0.7265]
115          placebo   ramelteon 0.8204 [0.4867; 1.3828]
120      eszopiclone     placebo 0.9824 [0.5183; 1.8620]
122          placebo   zopiclone 0.6260 [0.2396; 1.6354]
127          placebo   ramelteon 0.8204 [0.4867; 1.3828]
129        melatonin     placebo 0.7313 [0.2013; 2.6569]
130        melatonin     placebo 0.7313 [0.2013; 2.6569]
132          placebo   trazodone 0.4039 [0.1307; 1.2477]
132        trazodone    zolpidem 1.1722 [0.3875; 3.5462]
132          placebo    zolpidem 0.4734 [0.3085; 0.7265]
134          placebo    zaleplon 0.7511 [0.4338; 1.3005]
135          placebo    zolpidem 0.4734 [0.3085; 0.7265]
137          placebo    zolpidem 0.4734 [0.3085; 0.7265]
142 BZD-intermediate     placebo 1.5087 [0.7503; 3.0340]
144      eszopiclone     placebo 0.9824 [0.5183; 1.8620]
145          placebo   ramelteon 0.8204 [0.4867; 1.3828]
149 BZD-intermediate   trazodone 0.6094 [0.1721; 2.1575]
153      lemborexant    zolpidem 0.4175 [0.1349; 1.2926]
153          placebo    zolpidem 0.4734 [0.3085; 0.7265]
153      lemborexant     placebo 0.8819 [0.2739; 2.8402]
158          placebo seltorexant 1.0132 [0.2453; 4.1844]
158          placebo    zolpidem 0.4734 [0.3085; 0.7265]
158      seltorexant    zolpidem 0.4673 [0.1131; 1.9297]

Number of studies: k = 40
Number of pairwise comparisons: m = 59
Number of observations: o = 13008
Number of treatments: n = 14
Number of designs: d = 19

Fixed effects model

Treatment estimate (sm = 'OR', comparison: other treatments vs 'BZD-intermediate'):
                     OR           95%-CI     z p-value
BZD-intermediate      .                .     .       .
BZD-short        0.8160 [0.2598; 2.5631] -0.35  0.7277
daridorexant     0.7587 [0.0791; 7.2750] -0.24  0.8108
doxepin          1.0011 [0.2674; 3.7476]  0.00  0.9986
eszopiclone      0.6511 [0.2603; 1.6284] -0.92  0.3589
lemborexant      0.5845 [0.1516; 2.2545] -0.78  0.4356
melatonin        0.4847 [0.1118; 2.1020] -0.97  0.3333
placebo          0.6628 [0.3296; 1.3329] -1.15  0.2486
ramelteon        0.8079 [0.3377; 1.9325] -0.48  0.6317
seltorexant      0.6542 [0.1356; 3.1563] -0.53  0.5971
trazodone        1.6411 [0.4635; 5.8105]  0.77  0.4425
zaleplon         0.8825 [0.3672; 2.1206] -0.28  0.7799
zolpidem         1.4000 [0.6345; 3.0891]  0.83  0.4047
zopiclone        1.0588 [0.3448; 3.2513]  0.10  0.9205

Random effects model

Treatment estimate (sm = 'OR', comparison: other treatments vs 'BZD-intermediate'):
                     OR           95%-CI     z p-value
BZD-intermediate      .                .     .       .
BZD-short        0.8160 [0.2598; 2.5631] -0.35  0.7277
daridorexant     0.7587 [0.0791; 7.2750] -0.24  0.8108
doxepin          1.0011 [0.2674; 3.7476]  0.00  0.9986
eszopiclone      0.6511 [0.2603; 1.6284] -0.92  0.3589
lemborexant      0.5845 [0.1516; 2.2545] -0.78  0.4356
melatonin        0.4847 [0.1118; 2.1020] -0.97  0.3333
placebo          0.6628 [0.3296; 1.3329] -1.15  0.2486
ramelteon        0.8079 [0.3377; 1.9325] -0.48  0.6317
seltorexant      0.6542 [0.1356; 3.1563] -0.53  0.5971
trazodone        1.6411 [0.4635; 5.8105]  0.77  0.4425
zaleplon         0.8825 [0.3672; 2.1206] -0.28  0.7799
zolpidem         1.4000 [0.6345; 3.0891]  0.83  0.4047
zopiclone        1.0588 [0.3448; 3.2513]  0.10  0.9205

Quantifying heterogeneity / inconsistency:
tau^2 = 0; tau = 0; I^2 = 0% [0.0%; 37.4%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                    Q d.f. p-value
Total           21.86   36  0.9694
Within designs  12.01   22  0.9572
Between designs  9.85   14  0.7728
[1] "A total of 14 treatments are included in the network."
[1] "A total of 40 studies are included in this analysis."
[1] "Estimated heterogeneity tau-squared0"
[1] "Global test for inconsistency, p-value 0.77278 (Q=10, d.o.f. 14)"
[1] "File created on 2022-01-30"
